Patients with moderate to severe papulopustular rosacea have better outcomes with low-dose minocycline than with placebo and ...

The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea in ...

The new capsule formulation of the antibiotic minocycline hydrochloride has been cleared by the US regulator to treat the inflammatory lesions caused by rosacea – which causes flushing or long ...

Journey Medical (DERM) announced that full results from two Phase 3 multicenter, randomized, double-blind, parallel-group, active-comparator ...

An increasing amount of evidence suggests that the FDA-approved antibiotic minocycline might have neuroprotective effects in animal models of various neurodegenerative disorders, and Gordon et al.